June 29, 2020 / 5:13 AM / 8 days ago

BRIEF-Targovax Enters Collaboration With Oblique

June 29 (Reuters) - Targovax ASA:

* TARGOVAX AND OBLIQUE ENTER COLLABORATION TO TARGET MUTANT RAS CANCERS BY

* TARGOVAX AND OBLIQUE WILL JOINTLY EXPLORE FEASIBILITY AND ANTI-CANCER POTENTIAL OF MERGING THEIR ONCOS AND ABIPROT TECHNOLOGY PLATFORMS

* ONCOS WILL BE USED TO DELIVER ABIPROT ANTIBODIES AGAINST HARD-TO-REACH TARGETS SUCH AS MUTANT RAS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below